Show simple item record

dc.contributor.authorVan Cutsem, Eric
dc.contributor.authorChao, Joseph
dc.contributor.authorFuchs, Charles S.
dc.contributor.authorShitara, Kohei
dc.contributor.authorTabernero, Josep
dc.contributor.authorMuro, Kei
dc.contributor.authorBang, Yung-Jue
dc.contributor.authorDe Vita, Ferdinando
dc.contributor.authorLanders, Greg A.
dc.contributor.authorYen, Chia-Jui
dc.contributor.authorChau, Ian
dc.contributor.authorElme, Anneli
dc.contributor.authorLee, Jeeyun
dc.contributor.authorOzguroglu, Mustafa
dc.contributor.authorCatenacci, Daniel V. T.
dc.contributor.authorLi, Xiaodong
dc.contributor.authorShih, Chie-Schin
dc.contributor.authorShah, Sukrut
dc.contributor.authorBhagia, Pooja
dc.contributor.authorWainberg, Zev A.
dc.date.accessioned2021-03-03T20:29:41Z
dc.date.available2021-03-03T20:29:41Z
dc.identifier.citationChao J., Fuchs C. S. , Shitara K., Tabernero J., Muro K., Van Cutsem E., Bang Y., De Vita F., Landers G. A. , Yen C., et al., "Pembrolizumab (pembro) in microsatellite instability-high (MSI-H) advanced gastric/gastroesophageal junction (G/GEJ) cancer by line of therapy", Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology, San-Francisco, Kostarika, 23 - 25 Ocak 2020, cilt.38
dc.identifier.othervv_1032021
dc.identifier.otherav_5a318671-399c-4bdf-b18f-54cc87fe65db
dc.identifier.urihttp://hdl.handle.net/20.500.12627/63407
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectOnkoloji
dc.titlePembrolizumab (pembro) in microsatellite instability-high (MSI-H) advanced gastric/gastroesophageal junction (G/GEJ) cancer by line of therapy
dc.typeBildiri
dc.contributor.department, ,
dc.identifier.volume38
dc.contributor.firstauthorID2277906


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record